AI-generated summary
The authors used human gingival fibroblasts in culture to test whether repeated 660 nm photobiomodulation after photodynamic therapy with indocyanine green affects cell viability. Viability fell after photodynamic therapy alone, while viability rose significantly in the groups given two or three 660 nm treatments on the first day of incubation. The authors conclude that repeated 660 nm treatments may increase fibroblast viability after this photodynamic therapy.
- Who or what was studied
- Human gingival fibroblasts obtained and cultured in vitro
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- This is an in vitro cell study, so results may not translate to living tissue or patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Total energy
- 24 J, 7.2 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photodynamic therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.